Healthcare ❯ Pharmaceuticals

Vaccine Development

Clinical Trials COVID-19 Vaccines mRNA Vaccines mRNA Technology Public Health Covid-19 Nasal Spray Vaccines Regulatory Approval Vaccine Safety Moderna Protein-based Vaccines Market Competition Legal Issues Vaccine Manufacturing Regulatory Affairs Regulatory Oversight Regulatory Agencies International Cooperation Vaccine Efficacy Future Vaccines Bavarian Nordic Covid-19 Vaccine Approval Emergency Use Authorization AstraZeneca Market Impact

FDA Weighs Ending Pfizer COVID-19 Authorization for Children Under 5

If the authorization ends, providers will rely on off-label shots that carry risks of insurance coverage lapses or supply shortages.

Moderna Cuts 10% of Global Workforce in Major Cost Overhaul

FDA Approves Moderna’s mNEXSPIKE for Seniors and High-Risk Adults as CDC Drops Recommendations for Healthy Children and Pregnant Women

FDA Grants Limited Approval to Novavax’s COVID-19 Vaccine